Home » Diseases » In dogs » Myelodystrophy, Leukosdystrophy (Degeneration in the Central Nervous System, Afghan Myelopathy)

Myelodystrophy, Leukosdystrophy (Degeneration in the Central Nervous System, Afghan Myelopathy) in Dogs

Occurrence: very rare
Location of disease: Head/Neck

Author: Dr. med. vet. Gisa Löwe | Last modified: 17.02.2026

When to visit the vet?

Non-urgent see a veterinarian within 2–3 days

If the condition worsens / symptoms persist, consult a veterinarian.

Definition

Myelodystrophy, also known as leukodystrophy or Afghan myelopathy, is a genetic disease that leads to degeneration of the central nervous systemThe CNS (central nervous system) consists of the brain and spinal cord. It is responsible for processing information and controls most functions of the body and behavior. in dogs. This disease particularly affects the white matter in the brain and spinal cordThe spinal cord is a long, narrow bundle of nerve tissue located in the spinal canal of the vertebral column. It is part of the central nervous system and transmits nerve impulses between the brain and body. and is primarily known in Afghan Hounds.

The most important facts at a glance

Myelodystrophy, also known as leukodystrophy or Afghan myelopathy, is a genetically determined disease that primarily affects Afghan Hounds and causes degeneration of the central nervous systemThe CNS (central nervous system) consists of the brain and spinal cord. It is responsible for processing information and controls most functions of the body and behavior., particularly the myelin layer of nerve fibers. This disease leads to disruption of neuronal communication and is inherited in an autosomal recessive manner, meaning affected dogs need two copies of the mutated gene to develop symptoms. Common symptoms include movement disorders of the hind legs, uncoordinated gait, and tremors. Rarely, complete paralysisParalysis is the complete loss of muscle activity in one or more areas of the body, which can lead to immobility and loss of sensation. Paralysis can be caused by injuries, illnesses, or disorders of the nervous system. of the legs and urinary incontinenceIncontinence refers to the inability to voluntarily control urine or stool, leading to involuntary loss. There are various forms, including urinary incontinence and fecal incontinence, which can be caused by different factors. may occur. DiagnosisA diagnosis is the identification of a disease or condition by its symptoms and/or results from diagnostic tests. It is the first step in the management and treatment of patients. is made through clinical examinations, imaging procedures such as MRI, and genetic tests to identify specific mutations.

A cure does not currently exist; treatment focuses on alleviating symptoms and improving quality of life through physiotherapyVeterinary physiotherapy encompasses a range of treatment methods aimed at improving the mobility and well-being of animals through exercise, massage, and other manual techniques., medications, and nutritional support. The prognosisThe prognosis is the prediction of the likely course and outcome of a disease based on the general state of health, the nature of the disease, and the response to treatment. It can provide information on how a disease is expected to develop. is unfavorable, as the disease is progressiveProgressive describes a condition or disease that worsens over time. This term is often used to characterize the course of an illness that causes increasingly severe symptoms or damage. and usually leads to significant neurological impairments. Preventive measures include responsible breeding practices and genetic testing to identify carriers of the mutationA mutation is a permanent change in the DNA sequence (genetic material) of an organism. In dogs and cats, mutations can lead to genetic diseases or desirable changes in certain traits. and avoid breeding them. Research focuses on identifying genetic markers and developing potential therapies, including gene therapyTherapy refers to the treatment of diseases or disorders with the aim of alleviating symptoms, promoting healing, or improving quality of life. Therapies can be medicinal, surgical, or through other medical interventions. approaches, to slow or stop the disease. Environmental factors are also being investigated to develop preventive measures to improve the well-being of affected dogs.

Causes

Myelodystrophy in dogs is a type of leukodystrophy characterized by progressiveProgressive describes a condition or disease that worsens over time. This term is often used to characterize the course of an illness that causes increasingly severe symptoms or damage. degeneration of the myelin sheaths. Myelin is a fatty substance that envelops and insulates nerve fibers, enabling efficient transmission of nerve impulses. In diseases like myelodystrophy, the integrity of the myelin layer is disrupted, impairing neuronal communication.

The disease is genetic and frequently occurs in certain breeds, particularly Afghan Hounds. Scientific studies suggest that it is an autosomal recessive hereditary disease, meaning a dog must inherit two copies of the mutated gene from both parents to develop the disease.

The exact genetic mutations that lead to myelodystrophy have been identified in some cases. Researchers are working to better understand the specific gene alterations to improve diagnoses and potential treatments. The identification of genetic markers could help in the future to detect affected dogs early and thus adjust breeding strategies.

Symptoms

Very common symptoms:

Common symptoms:

Rare symptoms:

The symptoms of myelodystrophy in dogs often begin at a young age, usually between the fourth and sixth month of life. Early signs include coordination disorders, also called ataxia, which may manifest as an unsteady gait, stumbling, or loss of fine motor skills.

As the disease progresses, dogs may also develop paralysisParalysis is the complete loss of muscle activity in one or more areas of the body, which can lead to immobility and loss of sensation. Paralysis can be caused by injuries, illnesses, or disorders of the nervous system.. This paralysisParalysis is the complete loss of muscle activity in one or more areas of the body, which can lead to immobility and loss of sensation. Paralysis can be caused by injuries, illnesses, or disorders of the nervous system. often affects the hind legs first but can also affect the front legs and other body parts in advanced stages. Muscle strength decreases, and muscle atrophyMuscle atrophy is the loss of muscle mass that can be caused by inactivity, malnutrition, or certain diseases. In dogs and cats, muscle atrophy can occur due to chronic diseases, aging, or after prolonged immobilization. may occur.

Additional symptoms may include behavioral changes such as apathy or irritability, as well as sensorySensory refers to the senses or perception. Sensory systems in dogs and cats include sight, hearing, smell, taste, and touch, all of which are central to interacting with their environment. impairments. In severe cases, convulsions may also occur. The course of the disease is often variable but unfortunately usually progressiveProgressive describes a condition or disease that worsens over time. This term is often used to characterize the course of an illness that causes increasingly severe symptoms or damage. and worsens over time.

Diagnosis

The diagnosisA diagnosis is the identification of a disease or condition by its symptoms and/or results from diagnostic tests. It is the first step in the management and treatment of patients. of myelodystrophy is based on a combination of clinical symptoms, breed predispositionA predisposition is an innate inclination or susceptibility of an organism to certain diseases or conditions. In dogs and cats, there may be a genetic predisposition to certain conditions such as hip dysplasia or certain heart diseases., and specific diagnostic tests. A veterinarian will first conduct a thorough physical examination and analyze the dog’s medical historyThe medical history is the systematic collection of a patient's medical history through questioning. It includes information about previous illnesses, treatments, allergies, and lifestyle habits..

Advanced imaging techniques such as magnetic resonance imaging (MRI)Magnetic resonance imaging is an imaging technique that uses strong magnetic fields and radio waves to create detailed images of the inside of the body. It is used in veterinary medicine to diagnose diseases of the brain, spine, and other organs. can be used to visualize changes in the white matter of the brain and spinal cordThe spinal cord is a long, narrow bundle of nerve tissue located in the spinal canal of the vertebral column. It is part of the central nervous system and transmits nerve impulses between the brain and body.. These changes are characteristic of leukodystrophies and support the diagnosisA diagnosis is the identification of a disease or condition by its symptoms and/or results from diagnostic tests. It is the first step in the management and treatment of patients..

A genetic test can also be performed to identify the specific mutations responsible for the disease. These tests are particularly useful for distinguishing the disease from other neurological disorders that may show similar symptoms.

Therapy

Currently, there is no cure for myelodystrophy in dogs, and treatment aims to relieve symptoms and improve the quality of life of the affected animal. PhysiotherapyVeterinary physiotherapy encompasses a range of treatment methods aimed at improving the mobility and well-being of animals through exercise, massage, and other manual techniques. can help maintain muscle strength and coordination for as long as possible.

In some cases, medications may be prescribed to control certain symptoms such as pain or convulsions. These therapies can improve quality of life, even though they cannot halt the progressiveProgressive describes a condition or disease that worsens over time. This term is often used to characterize the course of an illness that causes increasingly severe symptoms or damage. nature of the disease.

Nutritional support and supplements that promote nerve health may also be beneficial. Close collaboration with a veterinarian is crucial to create an individualized treatment plan tailored to the specific needs of the dog.

Prognosis and follow-up care

The prognosis for dogs with myelodystrophy is unfortunately unfavorable. The disease is progressive and typically leads to deterioration of neurological functions over time. Most affected dogs do not reach adulthood, as the progressiveProgressive describes a condition or disease that worsens over time. This term is often used to characterize the course of an illness that causes increasingly severe symptoms or damage. degeneration of the nervous system ultimately leads to severe impairments and complications.

In some cases, quality of life can be improved through symptomatic treatments and supportiveSupportive refers to supportive treatments that aim to alleviate symptoms and improve quality of life without directly treating the underlying cause of the disease. care, but the long-term prognosisThe prognosis is the prediction of the likely course and outcome of a disease based on the general state of health, the nature of the disease, and the response to treatment. It can provide information on how a disease is expected to develop. remains poor. However, early diagnosis and initiation of supportiveSupportive refers to supportive treatments that aim to alleviate symptoms and improve quality of life without directly treating the underlying cause of the disease. measures can help slow the progressionProgression refers to the advancement or worsening of a disease over time. It describes an increase in the severity or extent of the disease symptoms. of the disease and improve the animal’s well-being.

Prevention

Since myelodystrophy is a genetic disease, the best preventionPrevention includes measures taken to prevent diseases or injuries. In veterinary medicine, this includes vaccinations, parasite control, and health monitoring. strategy lies in responsible breeding practices. Breeders can use genetic tests to identify carriers of the disease-causing mutations and avoid breeding two carriers together.

A better understanding of the genetic basis of the disease could lead to improved screening methods in the future. Through breeding selectionSelection refers to the process of natural or artificial selection of specific individuals for reproduction, based on desired genetic traits. In breeding, this is applied to promote specific characteristics in dogs and cats. and genetic testing, the incidenceIncidence refers to the number of new cases of a disease or condition that occur within a specific time period in a specific population group. It provides information about the risk of contracting the disease. of the disease in affected breeds can potentially be reduced.

Furthermore, educating breeders and owners about the nature of the disease and the importance of genetic testing can help reduce the occurrence of the disease in the dog populationIn veterinary medicine, the term population refers to a group of animals of a particular species living in a specific geographic area or environment.. Collaboration with veterinary geneticists and participation in breeding programs aimed at reducing genetic diseases are important steps toward preventionPrevention includes measures taken to prevent diseases or injuries. In veterinary medicine, this includes vaccinations, parasite control, and health monitoring..

Outlook on current research

Myelodystrophy, also known as leukodystrophy or Afghan myelopathy, is a genetically determined neurological disease primarily observed in Afghan Hounds. This disease affects the central nervous systemThe CNS (central nervous system) consists of the brain and spinal cord. It is responsible for processing information and controls most functions of the body and behavior., particularly the spinal cordThe spinal cord is a long, narrow bundle of nerve tissue located in the spinal canal of the vertebral column. It is part of the central nervous system and transmits nerve impulses between the brain and body., and leads to progressiveProgressive describes a condition or disease that worsens over time. This term is often used to characterize the course of an illness that causes increasingly severe symptoms or damage. degeneration of the white matter. The exact cause of myelodystrophy is not yet fully understood, but it is believed that genetic mutations play a central role.

Current research is intensively searching for the genetic markers responsible for susceptibility to this disease. Using modern genetic analysis techniques, such as genome sequencing, scientists are attempting to identify specific genes or genetic variants associated with the disease. Veterinarians and geneticists are working together to develop genetic tests that enable early identification of carriers of the gene defect. This could improve breeding strategies and help reduce the spread of the disease in the dog populationIn veterinary medicine, the term population refers to a group of animals of a particular species living in a specific geographic area or environment..

Another focus of research is on developing therapies to slow or even stop the progressionProgression refers to the advancement or worsening of a disease over time. It describes an increase in the severity or extent of the disease symptoms. of the disease. This also includes investigating potential drug candidates that could alleviate the symptoms of myelodystrophy. In addition to pharmacological research, there are also approaches based on gene therapyTherapy refers to the treatment of diseases or disorders with the aim of alleviating symptoms, promoting healing, or improving quality of life. Therapies can be medicinal, surgical, or through other medical interventions.. These could offer a future possibility to directly correct the underlying genetic defects and thus prevent the development of the disease.

Furthermore, the role of environmental factors and their influence on disease progressionProgression refers to the advancement or worsening of a disease over time. It describes an increase in the severity or extent of the disease symptoms. is being investigated. It is suspected that certain environmental conditions could worsen or influence the symptoms of myelodystrophy. By understanding these factors, researchers hope to develop preventive measures that can improve the well-being of affected dogs.

Frequently asked questions (FAQs)

What is myelodystrophy in dogs?

Myelodystrophy, also known as leukodystrophy or Afghan myelopathy, is a genetic disease that affects the central nervous system of dogs. It leads to degeneration of the white matter in the spinal cord and causes neurological symptoms. -

Which dog breeds are most commonly affected?

The disease occurs most frequently in Afghan Hounds but can also occur in other breeds, although more rarely. The genetic predisposition is particularly pronounced in Afghans. -

What symptoms do dogs with myelodystrophy show?

The most common symptoms include coordination disorders, paralysis, muscle weakness, and balance problems. The disease is progressive, and symptoms worsen over time. -

How is myelodystrophy diagnosed?

Diagnosis is typically made through a combination of clinical examinations, neurological tests, and imaging procedures such as MRI or CT. Genetic tests can be used to confirm the diagnosis. -

Is there a cure for myelodystrophy?

Currently, there is no cure for myelodystrophy. Treatment focuses on alleviating symptoms and improving the quality of life of the affected dog. -

What treatment options are available for affected dogs?

Treatment typically includes physiotherapy measures, supportive care, and possibly medications to relieve symptoms such as pain and muscle spasms. The veterinarian can create an individualized treatment plan. -

Can genetic tests help with breeding?

Yes, genetic tests can help breeders identify carriers of the disease and thus reduce the spread of the disease in the population. Through targeted breeding strategies, the risk of disease inheritance can be reduced. -

What progress is being made in myelodystrophy research?

Research focuses on identifying genetic causes, developing genetic tests, and potential therapies. Gene therapy and pharmacological approaches are promising fields being further investigated. -

Is myelodystrophy comparable in humans and dogs?

Although the disease shows similarities in humans and dogs, there are differences in genetic causes and disease progression. However, research in dogs can provide valuable insights for comparable diseases in humans. -

How can I help my dog with myelodystrophy?

It is important to ensure regular veterinary care and adhere to recommended treatments. An adapted environment and physiotherapy exercises can help improve the dog's quality of life.